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Purpose: Beaded filaments are lens cell-specific intermediate filaments composed of two proteins: filensin and phakinin
(CP49). Filensin and phakinin are believed to function in the maintenance of lens transparency. To elucidate the function
of filensin and phakinin at the molecular level, we examined the degradation of these two proteins in normal and cataractous
rat lenses.
Methods: A hereditary cataract model, the Shumiya cataract rat (SCR), was used for these studies. Anti-filensin antibodies
were raised against three different regions of the protein, the rod domain, the inner region of the tail domain, and the outer
region of the tail domain. Anti-filensin and anti-phakinin antibodies were used to examine the conformation of degradation
of filensin and phakinin by western blot analysis and fluorescent immunocytochemistry of cryosectioned lenses.
Results: In the normal lens, filensin was processed from a 94 kDa protein to proteins of 50 kDa and 38 kDa. Similarly,
phakinin was processed from a 49 kDa protein to one of 40 kDa. The concentrations of filensin and phakinin in the rat
lens cortex fluctuated with age and decreased during cataractogenesis. The 50 kDa form of filensin decreased significantly
before opacification. In the normal lens, phakinin, the filensin rod domain, and the filensin inner tail domain localized to
membrane lining regions in the shallow cortex and to the central region of the cytoplasm in the deep cortex. The COOH-
terminal domain of filensin localized to the membrane lining region in the deep cortex. In pre-cataractous lenses, phakinin
and the filensin rod domain localized primarily to the membranes lining the shallow cortex region and were distributed
throughout the cytoplasm of lens fiber cells in the deep cortex.
Conclusions: The 50 kDa form of filensin is important for the localization of beaded filaments in lens fiber cells and for
lens transparency.
The lens of the eye is composed of two types of cells,
epithelial cells, which form a monolayer at the anterior surface
of the lens, and lens fiber cells, which originate from epithelial
cells  and  are  highly  differentiated.  Lens  fiber  cells  lack
organelles, have lens-specific structures such as gap junctions
and beaded filaments, and synthesize lens-specific proteins.
Beaded  filaments  are  lens  fiber  cell-specific  intermediate
filaments  [1]  composed  of  two  proteins,  filensin  [2]  and
phakinin [3]. Beaded filaments are 15–20 nm in diameter and
consist of globular particles with a periodicity of 19–21 nm
[4]. Primary amino-acid sequence analysis shows that filensin
and phakinin are members of the intermediate filament family
of  proteins  [5-8].  Similar  to  other  intermediate  filament
proteins: the structure of filensin consists of a head domain, a
rod domain that can be divided into three subdomains (1A,
1B, and 2), and a COOH-terminal tail domain. Phakinin is
similar in structure to filensin but lacks a COOH-terminal tail
domain  [9].  Filensin  and  phakinin  copolymerize  to  form
beaded filaments at a stoichiometry of 1:2 to 1:3 both in vivo
and in vitro [9,10] but are unable to polymerize with vimentin,
another member of the intermediate filament protein family
[10].
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Beaded filament proteins are found exclusively in the
fiber cells of the lens in all vertebrate orders examined [11],
which suggests that beaded filaments play a critical role in
lens function. Previous studies have shown that the deletion
of filensin or phakinin expression in mice by gene targeting
causes cataracts and that some forms of hereditary cataracts
in humans are caused by mutations of filensin or phakinin
[12-17]. These data suggest that beaded filaments play an
important role in lens transparency. Full-length filensin is
processed into smaller fragments in the normal lens [18], but
the significance of its degradation and the function of the
degraded protein are unknown.
The Shumiya cataract rat (SCR) hereditary cataract was
derived from a congenic line of SHR-fa rats [19], and 66.7%
of the animals develop cataracts. Lens opacity first appears in
the nuclear and perinuclear regions in 11-week-old SCRs and
later develops into a mature cataract. Cataract SCR can be
distinguished from normal SCR at six weeks of age by slit-
lamp microscopy. The phenotype of the cataract SCR lens
manifests as wrinkles along the Y suture. In contrast, the
surface of the lens in normal rats and normal SCRs is smooth.
In  the  current  study,  we  examined  normal  and  pre-
cataract SCR lenses at 6 and 10 weeks of age and cataract SCR
lenses at 12 weeks of age to determine the role of filensin and
phakinin  degradation  and  localization  during  aging  and
cataractogenesis.
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Animals:  Wistar  rats  and  Japanese  white  rabbits  were
purchased from Sankyo Labo Service Corporation (Tokyo,
Japan). SCRs were bred at the Kyoritsu College of Pharmacy.
Six-week-old SCRs were divided into two groups, normal and
cataract, based on slit lamp microscopic observation of the Y
suture after mydriasis. All animal procedures conformed to
the  guidelines  of  the  Committee  of  the  Ethics  of  Animal
Experiments at the Kyoritsu University College of Pharmacy
(Tokyo, Japan).
Electrophoresis:  For  SDS–polyacrylamide  gel
electrophoresis (SDS–PAGE), rat lenses were homogenized
in homogenizing buffer (25 mM Tris-HCl, pH 8.0, 5 mM
EDTA, 5 mM EGTA, 1 mM PMSF). The homogenate was
centrifuged at 12,000x g at 4 °C for 20 min, and then the pellet
was washed twice with the homogenizing buffer. The pellet
was extracted with 8 M urea, 5 mM Tris-HCl, pH 8.0, 1 mM
EDTA, and 1 mM CaCl2 for 20 min. The extract was collected
after  centrifugation  at  13,000x  g  for  20  min  at  room
temperature.  SDS–PAGE  was  performed  using  a  7.5%
polyacrylamide resolving gel.
Anti-filensin and anti-phakinin antibodies: Total rat lens RNA
was extracted using TRIzol (Invitrogen Corp., Carlsbad, CA)
according  to  the  manufacturer’s  instructions.  Reverse
transcriptase  polymerase  chain  reaction  (RT–PCR)  was
performed using the TaKaRa RNA PCR™ Kit (AMV) v3.0
(TaKaRa,  Otsu,  Japan)  and  the  following  oligonucleotide
primers: 5′-GAA TTC ATG CTG GAA CGG CTG AAC
AA-3′ and 5′-CTC GAG TTA GGA TCC AAG GCT GAG
AGA GG-3′ for the filensin rod domain; 5′-GGA CCA TCT
GAA ATG ACC TTA-3′ and 5′-GTC ACT AAA CAC ACC
CAC TCT G-3′ for the filensin inner-tail domain; 5′-GGA
TCC CCT GGA CAG CCC ATG CCA CCT-3′ and 5′-CGG
TCG ACT CAA GCC TTG GCA TTT GAG-3′ for the filensin
outer-tail domain; and 5′-GGA TCC ATG CCA TTC AGG
AAG-3′ and 5′-CTC GAG TTA GTT GTT CTC CTC T-3′ for
phakinin.  Amplified  PCR  products  were  inserted  into  the
pGEX-6P-1 expression vector (GE Healthcare Life Sciences,
Buckinghamshire,  UK),  and  recombinant  filensin  and
phakinin  peptides  were  synthesized  according  to  the
manufacturer’s instructions.
The recombinant peptides were emulsified with Freünd’s
complete  adjuvant  (ICN  Pharmaceuticals,  Mesa,  CA)  and
then injected into Japanese white rabbits. The rabbits were
given  two  additional  injections  of  antigen  in  incomplete
Freünd's  adjuvant  (ICN  Pharmaceuticals)  at  two-week
intervals. Antisera were obtained by bleeding from the rabbit
ear artery.
Western blot analysis: Proteins were resolved by SDS–PAGE
and then transferred onto a nitrocellulose membrane. The
nitrocellulose membrane was blocked with 10% (w/v) skim
milk (Wako Pure Chemical Industries Ltd., Osaka, Japan) in
TBS (0.9% NaCl, 100 mM Tris-HCl, pH 7.5). Membranes
were  incubated  with  anti-filensin,  anti-phakinin,  and  anti-
vimentin  antibodies  followed  by  horseradish  peroxidase-
conjugated  anti-rabbit  antibody  (Bio-Rad  Laboratories,
Hercules, CA). Immunoreactive proteins were visualized with
0.05% diaminobenzidine (Wako Pure Chemical Industries
Ltd.)  and  0.006%  hydrogen  peroxide.  The  data  was
quantitated using Image J software.
Semi-quantitative  real-time  RT–PCR:  The  primers  for
quantitative PCR were designed using Primer Express 3.0
software (Applied Biosystems, Foster City, CA) according to
the manufacturer’s guidelines. The primers were synthesized
by Hokkaido System Science (Sapporo, Japan). The following
primer sequences were used: 5′-CCC TGG AAC AAG CTA
TTA AGC ATG-3′ and 5′-TTC CGG AGG TTT TCG ATC
TG-3′ for filensin; 5′-CTC CAG GCT GAG ACA GAA TCT
TTA C-3′ and 5′-TCA TGC CAG TGC TTG GCA T-3′ for
phakinin; and 5′-TCC TGT GGC ATC CAT GAA ACT AC-3′
and 5′-AGC ACT GTG TTG GCA TAG AGG TC-3′ for β-
actin. Reverse transcription was performed with 1 µg of total
RNA and the appropriate reverse primer using the TaKaRa
RNA PCR™ Kit (AMV) v3.0. The transcribed cDNA was
mixed  with  SYBR®  Green  PCR  Master  Mix  (Applied
Biosystems), and PCR was performed with the appropriate
forward primer using the ABI PRISM 7300 Real-Time PCR
System (Applied Biosystems). The reaction conditions were
as follows: 95 °C for 5 min; 40 cycles of 94 °C for 1 min,
55 °C for 45 s, and 72 °C for 30 s; and a final extension at
72 °C for 7 min.
Morphological  analysis  and  immunohistochemistry:  Rat
lenses were frozen in liquid nitrogen. The frozen lenses were
embedded in the OTC compound (VWR International Ltd.,
Poole, UK) chilled with acetone-liquid carbon dioxide and
then cryosectioned into 5 µm sections. The sections were
placed on polylysine-coated glass slides and fixed with 4%
paraformaldehyde in phosphate-buffered saline (PBS). The
sections  were  blocked  with  1%  BSA  in  TBS  and  then
incubated  with  anti-filensin  or  anti-phakinin  primary
antibodies  followed  by  FITC-conjugated  anti-rabbit
secondary antibody (Kirkegaard & Perry Laboratories Inc.,
Gaithersburg, MD).
RESULTS
Degradation  of  beaded  filament  proteins  in  pre-cataract
Shumiya cataract rat lenses: Figure 1 shows a western blot
analysis of intermediate filament proteins in water-insoluble,
urea-soluble  fractions  of  lenses  from  10-week-old  control
Wistar rats (lanes 1, 2), normal SCRs (lanes 3, 4), and pre-
cataract SCRs just before opacification (lanes 5, 6). A single
major  band  at  55  kDa  was  detected  by  the  anti-vimentin
antibody  (Figure  1A,  arrowhead).  Three  proteins  of
approximately 94, 50, and 38 kDa were detected by the anti-
filensin rod domain antibody (Figure 1B, arrowheads), and
the  anti-phakinin  antibody  detected  two  proteins  of
approximately 49 and 40 kDa (Figure 1C, arrowheads). The
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816amount of vimentin was the same in all three types of lens
(Figure 1A). In contrast, the 50 kDa form of filensin was
decreased significantly, and the 38 kDa form was increased
in  pre-cataract  lenses  as  compared  to  control  lenses.  In
particular,  the  50  kDa  form  of  filensin  was  markedly
decreased (Figure 1B, lanes 5, 6). Similarly, the intact 49 kDa
form of phakinin was decreased, and the 40 kDa form was
increased in pre-cataract lenses as compared to control lenses
(Figure 1C, lanes 5, 6).
Beaded-filament proteins in the cortices and nuclei of normal
and pre-cataract lenses: To clarify the functions of filensin
and phakinin in the maintenance of lens transparency, changes
in the protein levels of filensin and phakinin in the cortex and
nuclear regions of the lens were examined by SDS–PAGE and
western blot. The cortical and nuclear regions of Wistar, pre-
cataract SCR, and normal SCR lenses were separated, and the
levels of filensin and phakinin were examined at the age of 6,
10, and 12 weeks. Cataract SCRs can be distinguished from
normal SCRs at six weeks of age, and they develop cataracts
at 11 weeks of age. The levels of the 94 kDa form of filensin
in the cortical regions of normal, cataract SCR, and normal
SCR lenses were similar at six weeks of age. At 10 and 12
weeks of age, there was less 94 kDa filensin in the cortical
regions of cataract SCR lenses than in Wistar and normal SCR
lenses. The 94 kDa form of filensin was absent from the
nuclear regions of Wistar, cataract SCR, and normal SCR
lenses at 6, 10, and 12 weeks of age. The level of the 50 kDa
form of filensin was slightly lower at six weeks of age and
markedly decreased at 10 and 12 weeks of age in the cortex
of the cataract SCR lens as compared to Wistar and normal
SCR lenses. Overall, the level of 50 kDa filensin was lower
in nuclear regions than in cortical regions, and it was absent
from the nuclear regions of cataract SCR lenses at 6, 10, and
12 weeks of age. The cortical regions of 10- and 12-week-old
cataract SCR lenses contained more 38 kDa filensin than
Wistar and normal SCR lenses (Figure 2A).
In  six-week-old  cataract  SCRs,  the  49  kDa  form  of
phakinin was slightly degraded and the 40 kDa form appeared
Figure 1. Western blot analysis of intermediate filament proteins in
the lens. Western blot analysis of vimentin (A), filensin (B), and
phakinin (C) in the lenses of 10-week-old Wistar rats (lanes 1 and
2), normal SCRs (lanes 3 and 4), and pre-cataract SCRs (lanes 5 and
6) is shown. The levels of the 50 kDa form filensin and phakinin in
pre-cataract lenses were lower than in control lenses.
in the cortex of the lens (data not shown). At the age of 10
(Figure  2B)  and  12  weeks,  most  of  the  49  kDa  form  of
phakinin was degraded in cataract SCR lenses. Figure 2 shows
a western blot of filensin and phakinin in the cortical and
nuclear regions of 10-week-old Wistar, cataract SCR, and
normal SCR lenses. In cataract SCR lenses, both the 50 kDa
form  of  filensin  and  the  49  kDa  form  of  phakinin  were
degraded at 10 weeks of age
The relative intensity of each molecular weight form of
filensin in the cortical regions of cataract SCR and Wistar
lenses was quantitated using densitometry, and the results are
presented in Figure 3. The level of 94 kDa filensin was lower
in SCR lenses than in Wistar lenses at 6 weeks of age. At 10
Figure 2. Western blot analysis of filensin and phakinin in the 10-
week-old rat lens. SDS–PAGE and western blot analysis of the
cortical and nuclear regions of lenses from 10-week-old Wistar rats,
pre-cataract SCRs, and normal SCRs using an anti-filensin antibody
(A) and an anti-phakinin antibody (B) are shown. Ten micrograms
of protein were loaded in each lane (Lane 1, cortex of Wistar lens;
lane 2, cortex of pre-cataract SCR lens; lane 3, cortex of normal SCR
lens; lane 4, nucleus of Wistar lens; lane 5, nucleus of pre-cataract
SCR lens; lane 6, nucleus of normal SCR lens). The levels of filensin
and phakinin in the nuclear regions were lower in 10-week-old lenses
than in 6-week-old lenses. The 94 kDa form of filensin was absent
from the cortex of the pre-cataract SCR lens. The 50 kDa form of
filensin was decreased and the 38 kDa form was increased in the
cortices of pre-cataract lenses as compared to Wistar lenses.
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817and 12 weeks of age, the 94 kDa form of filensin was nearly
undetectable. The level of 50 kDa filensin in cataract SCR
lenses was approximately half the level in Wistar lenses at six
weeks of age and was undetectable at 10 and 12 weeks of age.
In contrast, cataract SCR lenses contained higher levels of 38
kDa filensin than Wistar lenses at 10 and 12 weeks of age. The
amount of 38 kDa filensin in SCR lenses was more than
fourfold higher than in Wistar lenses due largely to the very
low level of 38 kDa filensin in Wistar lenses.
To investigate the degradation of filensin in more detail,
western blot analysis was performed using antibodies specific
for the inner (Figure 4B) and outer regions (Figure 4C) of the
filensin tail domain. The anti-filensin rod domain antibody
recognized 94 kDa, 50 kDa, and 38 kDa forms of filensin, and
the levels of 94 kDa and 50 kDa filensin were lower in water-
soluble  fractions  than  in  water-insoluble  and  urea-soluble
fractions of pre-cataract SCR lenses (Figure 4A). The filensin
inner tail domain antibody recognized the 94 kDa and 50 kDa
forms of filensin but not the 38 kDa form of the protein. It also
recognized a peptide of 36 kDa in water-insoluble and urea-
soluble fractions (Figure 4B, arrowhead). In pre-cataract SCR
lenses, the 94 kDa and 50 kDa forms of filensin were lower
than in control lenses and the 36 kDa peptide was undetectable
(Figure  4B,  lane  5).  The  anti-filensin  outer  tail  domain
antibody recognized the 94 kDa form of filensin and the 36
kDa peptide but not the 50 kDa or 38 kDa forms of filensin.
Figure 3. The relative amounts of the 94 kDa, 50 kDa, and 38 kDa
forms of filensin in the rat lens. The amount of each of the molecular
weight forms of filensin in cataract SCR and Wistar lenses was
analyzed by western blot and then quantitated by scanning. The
amount of the 94 kDa, 50 kDa, and 38 kDa forms of filensin in
cataract SCR lenses is shown relative to Wistar lenses. Triangle, 94
kDa filensin; Square, 50 kDa filensin; Circle, 38 kDa filensin.
In pre-cataract SCR lenses, there was less 94 kDa filensin than
in Wistar and normal SCR lenses and the 36 kDa peptide
(arrowhead)  was  undetectable  (Figure  4C,  lane  5).  These
results suggested that the 94 kDa form of filensin is cleaved
into rod and tail domains of 50 kDa and 36 kDa, respectively,
and that the 50 kDa filensin rod domain is further cleaved to
generate a 38 kDa peptide. The predicted domain structure of
rat filensin is shown in Figure 4D, and the positions of the
amino acids that comprise the outer and inner tail domain
antigens  are  indicated  along  with  the  predicted  filensin
cleavage sites.
Histological analysis of rat lens fiber cells and the localization
of  filensin  and  phakinin  in  the  rat  cortical  region:  The
morphology of lens cells and the localization of filensin in the
shallow and deep cortices of the rat lens were examined in
cross-sectional  tissue  samples  using  the  anti-filensin  rod
domain antibody (Figure 5). Normal (Figure 5A,C,E,G) and
pre-cataract SCR lenses (Figure 5B,D,F,H) at 10 weeks of age
were incubated with anti-filensin rod domain antibody, and
then the sections were viewed by phase microscopy (Figure
5A-D) and fluorescence-microscopy (Figure 5E-H). In pre-
cataract SCR lenses, phase microscopy revealed the presence
of vacuoles in the lens fiber cells and the cellular architecture
was disordered (Figure 5B). In normal SCR lenses, the cells
were more regular in structure, but some cells were larger than
others and vacuoles were occasionally observed (not shown).
Fluorescence microscopy revealed a pattern of fluorescence
that corresponded to the outer edges of the lens fiber cells,
which indicated that filensin localizes to the membrane lining
regions  in  normal  lenses.  There  were  no  significant
differences  in  the  localization  of  filensin  in  the  shallow
cortices of Wistar, cataract SCR (Figures 5E,F), and normal
Figure 4. Western blot analysis of filensin. Western blot analysis was
performed using antibodies directed against the filensin rod domain
(A), the inner tail domain (B), and the outer tail domain (C). Water-
soluble fractions of 10-week-old Wistar (lanes 1), pre-cataract SCR
(lanes 2), and normal SCR (lanes 3) lenses; water-insoluble and urea-
soluble fractions of 10-week-old Wistar (lanes 4), pre-cataract SCR
(lanes 5), and normal SCR (lanes 6) lenses. Arrowheads in B and
C indicate the 36 kDa filensin peptide. The schematic representation
of the filensin rod and tail domains (D) shows the predicted antigen
sites (arrows) and cleavage sites (arrowheads).
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818SCR (data not shown) lenses. The cells of the normal rat lens
were smaller in the deep cortex than in the shallow cortex
(Figures 5A,C). In the deep cortex of the Wistar lens, anti-
filensin rod domain antibodies localized to the central region
of the cytoplasm in lens fiber cells (Figures 5C,G) whereas in
pre-cataract SCR lenses, filensin appeared to be distributed
throughout  the  fiber  cell  (Figures  5D,H).  We  observed  a
similar pattern of filensin distribution using the filensin inner
tail domain antibody (not shown).
We also examined the localization of filensin using a
COOH-terminal antibody directed against the outer region of
the filensin tail domain. Western blot analysis indicated that
the filensin outer tail domain antibody recognizes the 94 kDa
form of filensin but not the 50 kDa or 38 kDa forms of the
protein. In the shallow cortices of Wistar and pre-cataract SCR
lenses, anti-filensin outer tail domain antibodies localized to
the subcellular membrane regions (Figures 5I,J, respectively).
In the deep cortex of the Wistar lens, the antibody localized
to subcellular membrane regions (Figure 5K) whereas in pre-
cataract SCR lenses, the anti-filensin outer tail antibody was
distributed  throughout  the  cytoplasm  of  lens  fiber  cells
(Figure 5L).
When we performed a similar type of analysis using anti-
phakinin antibodies, we observed that phakinin localizes to
Figure 5. Localization of filensin and phakinin in the 10-week-old rat lens. The localization of filensin in 10-week-old rat lenses was examined
by phase-contrast microscopy (A-D) and fluorescence immunochemistry using antibodies directed against the filensin rod domain (E-H),
filensin outer tail domain (I-L), and phakinin (M-P). (A, E, I, and M) shallow cortex of the Wistar lens; (B, F, J, and N) shallow cortex of
the pre-cataract SCR lens; (C, G, K, and O) deep cortex of the Wistar lens; (D, H, L and P) deep cortex of the SCR lens. The anti-filensin
rod domain antibody localized to the membrane lining regions in the shallow cortices of Wistar and pre-cataract SCR lenses (E and F) and to
the central region of the cytoplasm in the deep cortex of the Wistar lens (G). The anti-filensin rod domain antibody exhibited a diffuse staining
pattern in the deep cortex of the cataract SCR lens (H). The anti-filensin outer tail domain antibody localized to the membrane lining region
of the shallow cortex of the Wistar (I) and pre-cataract SCR lens (J) as well as the deep cortex of the Wistar lens (K). This antibody exhibited
a diffuse staining pattern in the deep cortex of the pre-cataract SCR lens. The localization of phakinin (M-P) was similar to that of the filensin
rod domain (E-H). Scale bar, 10 µm.
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819subcellular membrane regions in the shallow cortices of both
Wistar and pre-cataract SCR lenses (Figure 5M,N). In the
deep  cortex  of  the  Wistar  lens,  anti-phakinin  antibodies
localized to the central region of the lens fiber cell cytoplasm
(Figure  5O).  In  pre-cataract  SCR  lenses,  phakinin  was
distributed throughout the fiber cell (Figure 5P). These results
indicated that the localization of phakinin is similar to filensin.
Semi-quantitative  analysis  of  filensin  and  phakinin
expression:  Semi-quantitative  RT–PCR  was  used  to
investigate the levels of filensin and phakinin mRNA in the
lens using the expression of beta-actin as a positive control
(Figure 6). No significant differences in the mRNA levels of
filensin and phakinin were observed among Wistar, cataract
SCR, or normal SCR lenses.
DISCUSSION
Degradation of filensin: Filensin is a 94 kDa intermediate
filament protein and a component of the beaded filament of
lens fiber cells. In this report, we have shown that filensin is
processed into two smaller molecular weight proteins of 50
and 38 kDa in the normal rat lens. It has been reported that
filensin is processed in a similar manner in normal bovine
lenses [18]. Using antibodies specific for different domains of
the protein, we have shown that both the 50 kDa and 38 kDa
forms of filensin contain the rod domain and the 50 kDa form
of filensin contains a portion of the tail domain that is adjacent
to the rod domain.
Presumably, the 50 kDa, 38 kDa, and 36 kDa forms of
filensin are products of proteolytic cleavage; however, there
are few known proteinases in the lens. Calpain is a calcium-
Figure  6.  Semi-quantitative  analysis  of  filensin  and  phakinin
mRNAs. The amounts of filensin and phakinin mRNA in pre-cataract
SCR and normal SCR lenses were analyzed by semi-quantitative
PCR. The data are presented relative to the levels in Wistar rat lenses
(1.0).  Solid  bars  represent  pre-cataract  SCR  lenses,  open  bars
represent normal SCR lenses. mRNA levels were normalized to the
level of cytoplasmic beta-actin mRNA. Data represents the means
and standard deviation of four independent experiments.
activated cysteine protease, and many isoforms of calpain
have been identified in the lens including calpain 2, calpain 3,
calpain 10, LP82, and LP85 in the lens [20-24]. However,
filensin is processed into 50 kDa, 38 kDa, and 36 kDa forms
in the normal lens in which calcium levels are very low,
suggesting  that  the  filensin  cleavage  products  are  not
generated by calpain. Calpains are activated by calcium, and
calcium  levels  rise  in  the  lens  after  the  onset  of
cataractogenesis. In the SCR lens, calpain has been suggested
to be the major proteinase involved in cataractogenesis [25].
Crystallins are also believed to be targets of calpain-mediated
degradation, and insoluble aggregates of truncated crystallin
have been proposed to play a role in the formation of cataracts
[26].
Additional candidate proteinases that are present in the
lens  are  caspase  and  the  proteasome.  Caspase  activates  a
DNase  that  is  involved  in  lens  development  and  nuclear
degeneration  [27],  and  proteasomes  are  involved  in  the
complete digestion of cellular proteins [28]. Thus, neither
caspase  nor  the  proteasome  are  likely  candidates  for  the
proteinase that cleave filensin.
In the pre-cataract SCR lens, the degradation of filensin
and phakinin was accelerated compared to normal rat lenses.
The mRNA sequences of filensin and phakinin are the same
in Wistar, cataract SCR, and normal SCR lenses (data not
shown).  Furthermore,  we  performed  a  semi-quantitative
analysis of filensin and phakinin mRNA levels and found that
they are similar in all three types of lens (Figure 6). This data
indicates that the degradation of filensin and phakinin in pre-
cataract SCR lenses is not caused by decreased transcription
or conformation changes brought about by alterations in the
primary  amino-acid  sequences  of  the  proteins.  Thus,  an
unidentified protease and/or peptidase is likely to be involved
in  the  degradation  of  filensin  and  phakinin.  Presumably,
different proteases are involved in generating the 50 and 38
kDa forms of filensin. Furthermore, generation of the 50 kDa
form of filensin may involve a different enzyme in cataract
SCRs than in normal rats.
Polymerization of filensin and phakinin and the role of beaded
filaments: Filensin and phakinin copolymerize into beaded
filaments at a molar ratio of 1:2 to 1:3 [9,10]. Structural studies
have  suggested  that  beaded  filaments  are  15–20  nm  in
diameter and that the “beads” have a periodicity of 19–21 nm
[4].  However,  a  detailed  molecular  structure  of  beaded
filaments has yet to be reported. It has been suggested that the
filensin tail domain comprises the bead portion of the beaded
filament [4]. It has also been reported that the bead portion
includes  a  third  component,  α-crystallin  [10].  Further
complicating the issue, other groups have suggested that the
beaded filament is smooth rather than beaded [9]. Thus, a clear
picture of the structure of beaded filaments is still emerging.
In  addition,  all  of  the  molecular  components  of  beaded
filaments have not been identified. In the current study, we
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820have shown that in the normal lens, the 94 kDa form of filensin
is degraded and that in the deep cortex, the filensin COOH-
terminal tail domain localizes to membrane lining regions
whereas the filensin rod domain and phakinin localize to the
central regions of lens fiber cells. These results suggest that
the COOH-terminal region of the tail domain of filensin is not
essential for the polymerization of beaded filaments.
In  the  normal  rat  lens,  the  filensin  rod  domain  and
phakinin localized to the membrane lining region in shallow
cortex cells and to the central region of the cytoplasm in deep
cortex cells. These results are in agreement with previous
studies of the mouse lens [29]. In cells of the deep cortex, the
filensin tail domain localized to subcellular membranes, but
the  filensin  rod  domain  did  not.  As  beaded  filaments  are
composed of both filensin and phakinin, the polymerized form
of beaded filaments should localize to subcellular membranes
in the shallow cortex and to the central region of lens fiber
cells in the deep cortex. The physiologic significance of the
transition from membrane lining regions to the central region
of the fiber cell during fiber cell differentiation is unknown.
It is possible that the beaded filament is necessary for the
formation of adhesion structures in young elongated fiber
cells  or  that  the  structure  that  underlies  the  fiber  cell
membrane  may  be  necessary  for  beaded  filament
polymerization in the shallow cortex of the lens. Polymerized
beaded  filaments  separate  from  the  cell  membrane  and
localize to the center of fiber cells where they may play an
important role in the maintenance of lens transparency. In the
deep cortex of pre-cataract SCR lenses, filensin and phakinin
were  distributed  throughout  the  cytoplasm.  This  result
indicates that filensin and phakinin are not incorporated into
beaded filaments in the deep cortex of pre-cataract SCR lenses
and that polymerized beaded filaments in deep cortex cells are
important for lens transparency.
The 50 kDa form of filensin was markedly decreased in
pre-cataract  and  cataract  lenses,  and  the  localization  of
filensin was disordered in the deep cortex of pre-cataract
lenses. These results indicate that the 50 kDa form of filensin
is important for the polymerization of beaded filaments and
lens transparency. The 38 kDa form of filensin was detected
at very low levels in the lens cortices of young animals, which
indicates that the 38 kDa form of filensin is not required for
beaded  filament  polymerization.  In  conclusion,  we  have
shown that polymerized beaded filaments are important for
lens transparency and that the 50 kDa form of filensin may be
a critical component of beaded filaments.
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